Unknown

Dataset Information

0

Scalable workflow for characterization of cell-cell communication in COVID-19 patients.


ABSTRACT: COVID-19 patients display a wide range of disease severity, ranging from asymptomatic to critical symptoms with high mortality risk. Our ability to understand the interaction of SARS-CoV-2 infected cells within the lung, and of protective or dysfunctional immune responses to the virus, is critical to effectively treat these patients. Currently, our understanding of cell-cell interactions across different disease states, and how such interactions may drive pathogenic outcomes, is incomplete. Here, we developed a generalizable and scalable workflow for identifying cells that are differentially interacting across COVID-19 patients with distinct disease outcomes and use this to examine eight public single-cell RNA-seq datasets (six from peripheral blood mononuclear cells, one from bronchoalveolar lavage and one from nasopharyngeal), with a total of 211 individual samples. By characterizing the cell-cell interaction patterns across epithelial and immune cells in lung tissues for patients with varying disease severity, we illustrate diverse communication patterns across individuals, and discover heterogeneous communication patterns among moderate and severe patients. We further illustrate patterns derived from cell-cell interactions are potential signatures for discriminating between moderate and severe patients. Overall, this workflow can be generalized and scaled to combine multiple scRNA-seq datasets to uncover cell-cell interactions.

SUBMITTER: Lin Y 

PROVIDER: S-EPMC9534414 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Scalable workflow for characterization of cell-cell communication in COVID-19 patients.

Lin Yingxin Y   Loo Lipin L   Tran Andy A   Lin David M DM   Moreno Cesar C   Hesselson Daniel D   Neely G Gregory GG   Yang Jean Y H JYH  

PLoS computational biology 20221005 10


COVID-19 patients display a wide range of disease severity, ranging from asymptomatic to critical symptoms with high mortality risk. Our ability to understand the interaction of SARS-CoV-2 infected cells within the lung, and of protective or dysfunctional immune responses to the virus, is critical to effectively treat these patients. Currently, our understanding of cell-cell interactions across different disease states, and how such interactions may drive pathogenic outcomes, is incomplete. Here  ...[more]

Similar Datasets

2023-03-24 | GSE188172 | GEO
| S-BSST416 | biostudies-other
| S-EPMC8551262 | biostudies-literature
2022-12-06 | E-MTAB-12392 | biostudies-arrayexpress
2020-12-31 | GSE153610 | GEO
| S-BSST1269 | biostudies-other
| S-EPMC7757730 | biostudies-literature
2023-07-26 | GSE227585 | GEO
2022-08-28 | GSE212041 | GEO
| S-BSST719 | biostudies-other